Mechanisms of Disease: Role of chondrocytes in the pathogenesis of osteoarthritis - Structure, chaos and senescence

Nature Clinical Practice Rheumatology

Volumn 3, Issue 7, 2007, Pages 391-399

  Aigner, Thomas ^a   Söder, Stefan ^b   Gebhard, Pia M ^b   McAlinden, Audrey ^b   Haag, Jochen ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GROWTH FACTOR;

APOPTOSIS; BIOSYNTHESIS; CALCIFICATION; CARTILAGE CELL; CARTILAGE DEGENERATION; CATABOLISM; CELL ACTIVATION; CELL AGING; CELL DEGENERATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; CELL PROLIFERATION; CELL STRUCTURE; CYTOPATHOLOGY; DISEASE COURSE; DNA DAMAGE; EXTRACELLULAR MATRIX; HUMAN; INFLAMMATION; OSTEOARTHRITIS; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ANIMALS; APOPTOSIS; CARTILAGE, ARTICULAR; CELL AGING; CELL PROLIFERATION; CHONDROCYTES; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; HUMANS; OSTEOARTHRITIS;

EID: 34447119750     PISSN: 17458382     EISSN: 17458390     Source Type: Journal    
DOI: 10.1038/ncprheum0534     Document Type: Review

References (56)

1. Stockwell RA (1967) The cell density of human articular cartilage and costal cartilage. J Anat 101: 753-763
2. Aigner T et al. (2004) Aging theories of primary osteoarthritis - from epidemiology to molecular biology. Rejuvenation Res 7: 134-145
3. Middleton JFS et al. (1996) Insulin-like growth factor (IGF) receptor, IGF-1, interleukin-1b (II-1b), and II-6 expression in osteoarthritic and normal human cartilage. J Histochem Cytochem 44: 133-141
4. Middleton JFS and Tyler JA (1992) Upregulation of insulin-like growth factor I gene expression in the lesions of osteoarthritic human articular cartilage. Ann Rheum Dis 51: 440-447
5. Bau B et al. (2002) Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro. Arthritis Rheum 46: 2648-2657
6. Chubinskaya S et al. (1999) Expression of matrix metalloproteinases in normal and damaged articular cartilage from human knee and ankle joints. Lab Invest 79: 1669-1677
7. Duerr S et al. (2004) MMP-2/gelatinase A is a gene product of human adult articular chondrocytes and increased in osteoarthritic cartilage. Clin Exp Rheumatol 22: 603-608
8. Hayman DM et al. (2006) The effects of isolation on chondrocyte gene expression. Tissue Eng 12: 2573-2581
9. Homandberg GA et al. (1998) Cartilage damaging activities of fibronectin fragments derived from cartilage and synovial fluid. Osteoarthritis Cartilage 6: 231-244
10. Yasuda T and Poole AR (2002) A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway. Arthritis Rheum 46: 138-148
11. Aydelotte MB et al. (1986) Articular chondrocytes cultured in agarose gel for study of chondrocytic chondrolysis. In Articular Cartilage Biochemistry, 235-256 (Eds Kuettner K et al.) New York: Raven Press
12. Smith GN Jr (2006) The role of collagenolytic matrix metalloproteinases in the loss of articular cartilage in osteoarthritis. Front Biosci 11: 3081-3095
13. Sandy JD (2006) A contentious issue finds some clarity: On the independent and complementary roles of aggrecanase activity and MMP activity in human joint aggrecanolysis. Osteoarthritis Cartilage 14: 95-100
14. Glasson SS et al. (2005) Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 434: 644-648
15. Stanton H et al. (2005) ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 434: 648-652
16. East CJ et al. (2007) ADAMTS-5 deficiency does not block aggrecanolysis at preferred cleavage sites in the chondroitin sulphate-rich region of aggrecan. J Biol Chem 282: 8632-8640
17. Song RH et al. (2007) Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5. Arthritis Rheum 56: 575-585
18. Aigner T et al. (1997) Suppression of cartilage matrix gene expression in upper zone chondrocytes of osteoarthritic cartilage. Arthritis Rheum 40: 562-569
19. Aigner T and Gerwin N (2007) Growth plate cartilage as developmental model in osteoarthritis research - potentials and limitations. Curr Drug Targets 8: 377-385
20. Aigner T et al. (1999) Reexpression of type IIA procollagen by adult articular chondrocytes in osteoarthritic cartilage. Arthritis Rheum 42: 1443-1450
21. Hambach L et al. (1998) Severe disturbance of the distribution and expression of type VI collagen chains in osteoarthritic articular cartilage. Arthritis Rheum 41: 986-996
22. Salter DM (1993) Tenascin is increased in cartilage and synovium from osteoarthritic knees. Br J Rheumatol 32: 780-786
23. Gebhard PM et al. (2003) Quantification of expression levels of cellular differentiation markers does not support a general shift in the cellular phenotype of osteoarthritic chondrocytes. J Orthop Res 21: 96-101
24. van der Kraan PM et al. (1998) Collagen type I antisense and collagen type IIA messenger RNA is expressed in adult murine cartilage. Osteoarthritis Cartilage 6: 417-426
25. Girkontaité I et al. (1996) Immunolocalization of type X collagen in normal fetal and adult osteoarthritic cartilage with monoclonal antibodies. Matrix Biol 15: 231-238
26. Merz D et al. (2003) IL-8/CXCL8 and growth-related oncogene alpha/ CXCL1 induce chondrocyte hypertrophic differentiation. J Immunol 171: 4406-4415
27. Bau B et al. (2002) Bone morphogenetic protein-mediating receptor-associated Smads as well as common Smad are expressed in human articular chondrocytes, but not upregulated or downregulated in osteoarthritic cartilage. J Bone Miner Res 17: 2141-2150
28. Kaiser M et al. (2004) BMP- and TGFβ-inhibitory Smads 6 and 7 are expressed in human adult normal and osteoarthritic cartilage in vivo and differentially regulated in vitro by Il-1β. Arthritis Rheum 11: 3535-3540
29. Weiss C (1973) Ultrastructural characteristics of osteoarthritis. Fed Proc 32: 1459-1466
30. Hulth A et al. (1972) Mitosis in human articular osteoarthritic cartilage. Clin Orthop Relat Res 84: 197-199
31. Aigner T et al. (2001) Apoptotic cell death is not a widespread phenomenon in normal aging and osteoarthritic human articular knee cartilage: A study of proliferation, programmed cell death (apoptosis), and viability of chondrocytes in normal and osteoarthritic human knee cartilage. Arthritis Rheum 44: 1304-1312
32. Kim HA et al. (2000) Apoptotic chondrocyte death in human osteoarthritis. J Rheumatol 27: 455-462
33. Blanco FJ et al. (1998) Osteoarthritic chondrocytes die by apoptosis. Arthritis Rheum 41: 284-289
34. Martin JA et al. (2004) Post-traumatic osteoarthritis: The role of accelerated chondrocyte senescence. Biorheology 41: 479-491
35. D'Lima DD et al. (2001) Human chondrocyte apoptosis in response to mechanical injury. Osteoarthritis Cartilage 9: 712-719
36. D'Lima D et al. (2006) Caspase inhibitors reduce severity of cartilage lesions in experimental osteoarthritis. Arthritis Rheum 54: 1814-1821
37. Loeser RF et al. (2000) Reduction in the chondrocyte response to insulin-like growth factor 1 in aging and osteoarthritis: Studies in a non-human primate model of naturally occurring disease. Arthritis Rheum 43: 2110-2120
38. Fan Z et al. (2005) Freshly isolated osteoarthritic chondrocytes are catabolically more active than normal chondrocytes, but less responsive to catabolic stimulation with II-1β. Arthritis Rheum 52: 136-143
39. Dai SM et al. (2006) Catabolic stress induces features of chondrocyte senescence through overexpression of caveolin 1: Possible involvement of caveolin 1-induced down-regulation of articular chondrocytes in the pathogenesis of osteoarthritis. Arthritis Rheum 54: 818-831
40. DeGroot J et al. (2004) Accumulation of advanced glycation end products as a molecular mechanism for aging as a risk factor in osteoarthritis. Arthritis Rheum 50: 1207-1215
41. Steenvoorden MM et al. (2006) Activation of receptor for advanced glycation end products in osteoarthritis leads to increased stimulation of chondrocytes and synoviocytes. Arthritis Rheum 54: 253-263
42. Loeser RF et al. (2005) Articular chondrocytes express the receptor for advanced glycation end products: Potential role in osteoarthritis. Arthritis Rheum 52: 2376-2385
43. Billinghurst RC et al. (1997) Enhanced cleavage of type II collagen by collagenase in osteoarthritic articular cartilage. J Clin Invest 99: 1534-1545
44. Mitchell PG et al. (1996) Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 97: 761-768
45. Yudoh K et al. (2005) Potential involvement of oxidative stress in cartilage senescence and development of osteoarthritis: Oxidative stress induces chondrocyte telomere instability and downregulation of chondrocyte function. Arthritis Res Ther 7: R380-R391
46. Martin JA et al. (2004) Effects of oxidative damage and telomerase activity on human articular cartilage chondrocyte senescence. J Gerontol A Biol Sci Med Sci 59: B324-B337
47. Hashimoto S et al. (1998) Linkage of chondrocyte apoptosis and cartilage degradation in human osteoarthritis. Arthritis Rheum 41: 1632-1638
48. Roach HI et al. (2004) Chondroptosis: A variant of apoptotic cell death in chondrocytes? Apoptosis 9: 265-278
49. Gebhard PM et al. (2004) Down-regulation of the GTPase RhoB might be involved in the pre-apoptotic phenotype of osteoarthritic chondrocytes. Front Biosci 9: 827-833
50. Aigner T et al. (2001) Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using complementary DNA-array technology. Arthritis Rheum 44: 2777-2789
51. Hall A (1998) Rho GTPases and the actin cytoskeleton. Science 279: 509-514
52. Liu AX et al. (2001) RhoB is required to mediate apoptosis in neoplastically transformed cells after DNA damage. Proc Natl Acad Sci USA 98: 6192-6197
53. Prendergast GC (2001) Actin' up: RhoB in cancer and apoptosis. Nat Rev Cancer 1: 162-168
54. Martel-Pelletier J et al. (2006) New thoughts on the pathophysiology of osteoarthritis: One more step toward new therapeutic targets. Curr Rheumatol Rep 8: 30-36
55. Pelletier JP et al. (2006) Most recent developments in strategies to reduce the progression of structural changes in osteoarthritis: Today and tomorrow. Arthritis Res Ther 8: 206
56. Abramson SB et al. (2006) Prospects for disease modification in osteoarthritis. Nat Clin Pract Rheumatol 2: 304-312